Cargando…
Human papillomavirus (HPV) testing for cervical cancer screening in a middle-income country: comment on a large real-world implementation study in China
Autores principales: | Thomsen, Louise T., Kjær, Susanne K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281637/ https://www.ncbi.nlm.nih.gov/pubmed/34261466 http://dx.doi.org/10.1186/s12916-021-02051-z |
Ejemplares similares
-
Clinical Performance of Human Papillomavirus (HPV) Testing versus Cytology for Cervical Cancer Screening: Results of a Large Danish Implementation Study
por: Thomsen, Louise T, et al.
Publicado: (2020) -
Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): Health system experiences and prospects()
por: Wigle, Jannah, et al.
Publicado: (2013) -
Comment on “Will HPV vaccination prevent cervical cancer”
por: Zhang, Shaokai, et al.
Publicado: (2020) -
Funders' Perspectives on Supporting Implementation Research in Low- and Middle-Income Countries
por: Cardoso-Weinberg, Ana, et al.
Publicado: (2022) -
Choosing Wisely—Barriers and Solutions to Implementation in Low and Middle-Income Countries
por: Rubagumya, Fidel, et al.
Publicado: (2022)